Description
Piroxicamisanon-steroidalanti-inflammatorydrug(NSAID)thatexhibitsanti-inflammatory,analgesic,antipyretic,neuroprotective,anticancer,andchemopreventiveactivities.PiroxicaminhibitsCOX-1andCOX-2.Cu(II)complexesofpiroxicambindGCsequencesofDNA.Inanimalmodels,thiscompounddecreasesdevelopmentofpolypsandcolorectalcancer.IncellularmodelsofParkinson’sdisease,piroxicaminhibitsMPP+-induceddecreasesinphosphorylatedAktandneurodegeneration.
References
ChakrabortyS,BoseM,SarkarM.SpectroscopicstudiesofthebindingofCu(II)complexesofoxicamNSAIDstoalternatingG-CandhomopolymericG-Csequences.SpectrochimActaAMolBiomolSpectrosc.2014Mar25;122:690-7.PMID:24345609.
BarkinRL.TopicalNonsteroidalAnti-InflammatoryDrugs:TheImportanceofDrug,Delivery,andTherapeuticOutcome.AmJTher.2012Feb22.[Epubaheadofprint].PMID:22367354.
TasakiY,YamamotoJ,OmuraT,etal.Oxicamstructureinnon-steroidalanti-inflammatorydrugsisessentialtoexhibitAkt-mediatedneuroprotectionagainst1-methyl-4-phenylpyridinium-inducedcytotoxicity.EurJPharmacol.2012Feb15;676(1-3):57-63.PMID:22182582.
QiuZF,MaruyamaK,SunayamaK,etal.Piroxicam-inducedregressionofintestinaladenomatouspolypsinAPC(delta474)mice.JInvestSurg.2003Mar-Apr;16(2):71-81.PMID:12746190.